 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/11/2024 |
$3.15 |
$3.15 |
$3.00 |
$3.03 |
3.46M | | 03/12/2024 |
$3.03 |
$3.04 |
$3.00 |
$3.00 |
89.10K | | 03/13/2024 |
$3.02 |
$3.05 |
$3.00 |
$3.02 |
227.50K | | 03/14/2024 |
$3.02 |
$3.09 |
$3.02 |
$3.09 |
153.10K | | 03/15/2024 |
$3.03 |
$3.09 |
$3.00 |
$3.02 |
980.50K |
 |
| Cyteir Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on developing of CYT-0851, an oral investigational drug candidate that inhibits monocarboxylate transporters. CYT-0851 is an investigational monocarboxylate transporter inhibitor (MCT) inhibitor, initially evaluated in a phase I/II study to treat patients with hematologic malignancies and solid tumors as a monotherapy and in combination with standard of care therapies. Inhibiting MCT function in glycolytic cancer cells leads to an accumulation of intracellular lactate that impairs glycolysis and inhibits tumor cell growth, making MCTs an attractive target for cancer therapy. | |
 |

Cyteir Therapeutics (CYT) has the following price history information. Looking back at CYT historical stock prices for the last five trading days, on March 11, 2024, CYT opened at $3.15, traded as high as $3.15 and as low as $3.00, and closed at $3.03. Trading volume was a total of 3.46M shares. On March 12, 2024, CYT opened at $3.03, traded as high as $3.04 and as low as $3.00, and closed at $3.00. Trading volume was a total of 89.10K shares. On March 13, 2024, CYT opened at $3.02, traded as high as $3.05 and as low as $3.00, and closed at $3.02. Trading volume was a total of 227.50K shares. On March 14, 2024, CYT opened at $3.02, traded as high as $3.09 and as low as $3.02, and closed at $3.09. Trading volume was a total of 153.10K shares. On March 15, 2024, CYT opened at $3.03, traded as high as $3.09 and as low as $3.00, and closed at $3.02. Trading volume was a total of 980.50K shares.
CYT Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyteir Therapeutics shares, starting with a $10,000 purchase of CYT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/21/2021 |
|
| End date: |
03/15/2024 |
|
| Start price/share: |
$17.32 |
|
| End price/share: |
$3.02 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-82.56% |
|
| Average Annual Total Return: |
-47.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,743.36 |
|
| Years: |
2.73 |
|
|
 |
| Date |
Close |
| 03/11/2024 | $3.03 | | 03/12/2024 | $3.00 | | 03/13/2024 | $3.02 | | 03/14/2024 | $3.09 | | 03/15/2024 | $3.02 |
|
 |